Luca Roncati is an Italian pathologist, academic editor of the European Journal of Gynaecological Oncology, physician-scientist, anti-cancer patent inventor, and medical lecturer with expertise in gynecological oncology, pediatric pathology, hematopathology, and soft tissue tumors. Known for the Roncati-Manenti triad and for T rex lymphoma, Luca Roncati is also dedicated to COVID-19 and nanopathology research. With a degree and a postgraduate diploma from the University of Modena and Reggio Emilia and with three teaching qualifications from the Italian Ministry of University, Luca Roncati continues to excel in pathology, oncology, gynecology, and forensic medicine, being an award-winning author with more than 270 peer-reviewed publications to his credit.